ESC Premium Access

Fibrosis as Measured by the Biomarker, Tissue Inhibitor Metalloproteinase 1, Predicts Mortality in Age Gene Environment Susceptibility Reykjavik (AGES Reykjavik) Study

Congress Presentation

About the speaker

Doctor Gina LaRocca

National Institutes of Health (NIH), Bethesda (United States of America)
1 presentation
0 follower

5 more presentations in this session

Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement: Insights from the MAUDE Database

Speaker: Associate Professor A. Kalra (Akron, US)


Prevalence of serious complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014

Speaker: Professor G. Steinbeck (Starnberg, DE)


Implementation of modern treatments explains improvements in outcomes after ST-Elevation Myocardial Infarction (STEMI) over a 20-year period in Sweden from 1995 to 2014

Speaker: Doctor K. Szummer (Stockholm, SE)


How can we explain the J curve in hypertensive patients with coronary artery disease? An analysis of 22,672 patients from the CLARIFY registry.

Speaker: Doctor E. Vidal-Petiot (Paris, FR)


Effectiveness of community atrial fibrillation screening in over 10,000 citizens using smartphone electrocardiogram- The AFinder program

Speaker: Doctor N. Chan (Hong Kong, HK)


Access the full session

Hot Line: Late-Breaking Registry Results 2

Speakers: Doctor G. LaRocca, Associate Professor A. Kalra, Professor G. Steinbeck, Doctor K. Szummer, Doctor E. Vidal-Petiot...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb